Galera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	18.26	4.32	19.86	15.87	18.36	14.81	6.17
Short-Term Investments	0	27.33	51.36	56.9	93.93	66.71	8.01
Cash & Cash Equivalents	18.26	31.65	71.22	72.78	112.29	81.52	14.18
Cash Growth	-42.31%	-55.56%	-2.14%	-35.19%	37.75%	474.87%	-
Other Current Assets	3.37	6.89	6.18	5.15	5.28	2.34	0.99
Total Current Assets	21.63	38.54	77.39	77.93	117.57	83.85	15.17
Property, Plant & Equipment	1.28	0.48	0.82	1.55	1.75	0.57	0.33
Goodwill and Intangibles	3.14	3.14	3.14	3.14	3.14	3.14	3.14
Other Long-Term Assets	0.09	1.88	1.96	1.48	0.92	0.5	0.24
Total Long-Term Assets	4.51	5.5	5.92	6.17	5.81	4.2	3.71
Total Assets	26.14	44.04	83.31	84.1	123.38	88.06	18.87
Accounts Payable	1.38	3.58	5.04	5.15	3.95	3.87	2.26
Current Debt	0.13	0.04	0.26	0.24	0.3	0	0
Other Current Liabilities	3.45	9.75	7.63	8.58	5.45	2.58	2.04
Total Current Liabilities	4.96	13.38	12.94	13.97	9.69	6.44	4.29
Long-Term Debt	1.12	0	0.04	0.3	0.53	0	0
Other Long-Term Liabilities	151.25	139.84	128.34	63.72	43.54	20.53	0.54
Total Long-Term Liabilities	152.37	139.84	128.38	64.01	44.07	20.53	0.54
Total Liabilities	157.33	153.22	141.32	77.98	53.77	26.97	4.83
Total Debt	1.25	0.04	0.3	0.53	0.83	0	0
Debt Growth	2740.91%	-85.43%	-43.45%	-35.74%	-	-	-
Retained Earnings	-437.41	-378.32	-316.1	-235.57	-161.35	-104.82	-76.1
Comprehensive Income	0	-0.02	-0.01	0.01	0.04	0	-0
Shareholders' Equity	-131.19	-109.18	-58	6.12	69.61	-104.82	-76.11
Net Cash / Debt	17.01	31.6	70.92	72.24	111.46	81.52	14.18
Net Cash / Debt Growth	-46.19%	-55.44%	-1.84%	-35.19%	36.73%	474.87%	-
Net Cash Per Share	0.38	1.17	2.75	2.90	30.75	271.18	47.17
Working Capital	16.67	25.16	64.46	63.96	107.88	77.41	10.87
Book Value Per Share	-2.94	-4.03	-2.25	0.25	19.20	-348.71	-253.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).